Recombinant Protein UK114 in Stable Polymer Form for Solid and Systemic Tumour Treatment
Summary
The European Patent Office has published patent application EP3554639A1 filed by Alberto Bartorelli Cusani for a recombinant protein UK114 in stable polymer form for use in treating or preventing malignant solid and systemic tumours. The application is classified under IPC codes A61K and A61P covering therapeutic preparations. The patent has been designated across all European Patent Convention member states.
What changed
The European Patent Office published patent application EP3554639A1 for a recombinant protein UK114 in stable polymer form. The invention relates to therapeutic use in treating or preventing malignant solid and systemic tumours. Filed by Alberto Bartorelli Cusani, the application is classified under A61K (preparations for medical purposes) and A61P (therapeutic activity). Designated states cover all EPC contracting states.
Pharmaceutical companies, biotech firms, and researchers in oncology should monitor this publication for potential freedom-to-operate considerations or licensing opportunities. The patent represents a novel therapeutic approach using recombinant protein technology for solid tumour treatment.
What to do next
- Monitor for updates
Archived snapshot
Apr 15, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
NOVEL RECOMBINANT PROTEIN UK 114 IN STABLE POLYMER FORM FOR USE IN THE TREATMENT OR PREVENTION OF MALIGNANT SOLID AND SYSTEMIC TUMOURS
Publication EP3554639A1 Kind: A1 Apr 08, 2026
Applicants
Bartorelli Cusani, Alberto
Inventors
Bartorelli Cusani, Alberto
IPC Classifications
A61K 38/50 20060101AFI20260227BHEP A61P 35/00 20060101ALI20260227BHEP A61K 38/16 20060101ALI20260227BHEP A61K 35/66 20150101ALI20260227BHEP A61K 39/00 20060101ALI20260227BHEP A61P 37/04 20060101ALI20260227BHEP
Designated States
AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
Named provisions
Related changes
Get daily alerts for EPO Patent Bulletin - Therapeutics (A61P)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from EPO.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when EPO Patent Bulletin - Therapeutics (A61P) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.